We examined the expression of all six core members of shelterin in early and advanced disease, and found significantly lower expression of RAP1 and TPP1 and reduced expression of TIN2 and TRF1 in advanced NSCLC. Here, TINF2 is linked to non-small cell lung carcinoma.